PROJECT MILESTONE DATES Sample Clauses

PROJECT MILESTONE DATES. Show dates on the diagram for start of project, any contract required interim completion dates, and contract completion dates.
Sample 1
AutoNDA by SimpleDocs
PROJECT MILESTONE DATES. The Parties shall work together in order to achieve the timely completion of the Project in accordance with the following timetable: Milestone Target Completion Date Effective Date Upon completion of condition precedents under Xxxxxx 19 Site Mobilization (location) : (date) Completion of the Project months from commercial operation date Commercial Operation Date (date) The duration of deployment for the power facility including the period for test and commissioning up to start of commercial operation is calendar days reckoned from the date of issuance of Notice of Award by ORMECO, Inc. During the course of generating unit project implementation, the WINNING BIDDER shall regularly provide ORMECO, Inc. an update report stating the progress and status of delivery of equipment and schedule of shipment. Failure of WINNING BIDDER to complete the Project or meet the Commercial Operation Date of the Project shall cause the forfeiture of the Performance Security, and WINNING BIDDER shall be liable to pay a monthly penalty in the amount equivalent to 1% of the Non-Fuel Cost, computed at the monthly contracted energy, for every day of delay after the scheduled Commercial Operation Date, but in no case the extension shall exceed two (2) months. Failure of WINNING BIDDER to complete the Project or meet the Commercial Operation Date after the two-month extension shall cause the automatic termination of this Agreement.
Sample 1
PROJECT MILESTONE DATES. The parties shall work together in order to endeavour to achieve the timely completion of the Project in accordance with the following timetable:- Stage Completed Date --------------- ---- Effective Date 30th June, 1992 Mobilisation 30th June, 1992 Commencement of Work 31st July, 1992 Target Completion Date of Unit 0 00xx Xxxx, 0000 Target Completion Date of Unit 0 00xx Xxxxxxx, 0000 Target Completion Date of Power Station 30th October, 1995
Sample 1
PROJECT MILESTONE DATES. 15 ----------------------- 3.2 DELAY IN ACHIEVING MILESTONE........................... 17 ---------------------------- 3.3 SPCC'S RIGHTS.......................................... 17 ------------- 3.4
Sample 1
PROJECT MILESTONE DATES. 3.1.1 SPCC shall commence development of the Cogeneration Power Production Facility on the Contract Signing Date and shall thereafter diligently pursue such work in order to achieve the timely completion of the Project and fulfill its other obligations under this Agreement in accordance within the following timetable: MILESTONE TARGET DATE (Months from Contract Signing Date) Posting of Development Bond within ten Days Completion of Documentary requirements Six (6) Calendar Months (Government Approvals) Issuance of Environmental Compliance Ten (10) Calendar Months Certificate Financial Closing Date Fifteen (15) Calendar Months Site/Project Mobilization Date Sixteen (16) Calendar Months Target Commercial Operation Date Forty-Four (44) Calendar Months Posting of O & M Bond within ten Days after Commercial Operation Date
Sample 1
PROJECT MILESTONE DATES. The parties shall work together to endeavour to achieve the timely completion of the Project in accordance with the following timetable: TARGET DATE WHICH IS A DATE FALLING BY THE FOLLOWING NUMBER OF CALENDAR MONTHS AFTER THE MILESTONE DATE HEREOF Submission of Feasibility Study Eleven (11) Submission of Environmental Impact Study Fifteen (15) Issue of Environmental Compliance Certificate Eighteen (18) Financial Closing Twenty-four (24) Site Mobilization Twenty-five (25) Target Completion Date of Unit 1 Fifty-eight (58) Target Completion Date of Unit 2 Sixty-one (61) Target Completion Date of Power Station Sixty-one (61)
Sample 1

Related to PROJECT MILESTONE DATES

  • Development Milestones In addition to its obligations under Paragraph 7.1, LICENSEE specifically commits to achieving the following development milestones in its diligence activities under this AGREEMENT: (a) (b).

  • Commercial Milestones In partial consideration of the rights granted by AstraZeneca to Licensee hereunder, Licensee shall pay to AstraZeneca the following payments, which shall be non-refundable, non-creditable and fully earned upon the first achievement of the applicable milestone event:

  • Milestone Event Milestone Payment [***] [***]

  • Development Milestone Payments In partial consideration for the rights and licenses granted to Coya hereunder, within ten days after the first achievement of each milestone event in a given Indication set forth in this Section 5.2 (Development Milestone Payments) with respect to a Product (each, a “Development Milestone Event”) by or on behalf of Coya or any of its Affiliates or Sublicensees, Coya shall provide ARScience Bio written notice to ARScience Bio identifying the Development Milestone Event achieved. Upon receipt of any such notice of first achievement of a Development Milestone Event by Coya or its Affiliates or Sublicensees, ARScience Bio will promptly invoice Coya for the applicable Development Milestone Event and Coya will make a milestone payment to ARScience Bio in the amount set forth in this Section 5.2 (Development Milestone Payments) corresponding to such Development Milestone Event (each, a “Development Milestone Payment”) within 45 days of receipt of such invoice. On an Indication-by-Indication basis, each Development Milestone Payment shall be payable only upon the first achievement of the corresponding Development Milestone Event by a Product, in any given Indication for which the Development Milestone Events have not been previously achieved (each such Indication, a “New Indication”). No amounts shall be due for subsequent or repeated achievements of such Development Milestone Event with respect to the same or different Mono Product or Combination Product, as applicable, in such Indication. Accordingly and for clarity, the Development Milestone Payment shall be paid only once, when first achieved by Coya, an Affiliate or a Sublicensee, but no payment shall be due if the same milestone is subsequently achieved by one of Coya, an Affiliate or a Sublicensee. For clarity, the amounts owed in Column (a) below shall be due for the first Combination Product to achieve the Development Milestone Events in a New Indication and the amounts owned in Column (c) below shall be due for the first Mono Product to achieve the Development Milestone Events in a New Indication. Any Combination Product or Mono Product to achieve the Development Milestone Events in a New Indication after the first achievement of the Development Milestone Events as described in the foregoing sentence will cause the amounts in Column (b) with respect to a Combination Product and Column (d) with respect to a Mono Product to be due and payable by Coya upon each such occurrence. If the first Product to achieve a Development Milestone Event in any Indication is a Combination Product, the amounts in Column (a) below shall be due and payable by Coya. If the next Product to achieve a Development Milestone Event in a New Indication is a Mono Product, the amounts in Column (c) below would be due and payable by Coya; provided, that if such next Product to achieve a Development Milestone Event in a New Indication is a Combination Product, the amounts in Column (b) would be due and payable by Coya. By way of example, if a Combination Product achieves IND Acceptance in ALS, and is the first Product to achieve a Development Milestone Event under this Agreement, [***] will be due and payable by Coya. If subsequently a Mono Product achieves IND Acceptance in ALS, no Development Milestone Payments will be due and payable by Coya under this Agreement. However, if subsequently any Combination Product achieves IND Acceptance in Alzheimer’s disease, [***] would be due and payable by Coya.

  • Regulatory Milestones Celgene shall make the following approval milestone payments to Jounce that are set forth below upon the first achievement by or on behalf of Celgene, its Affiliates or Sublicensees of the Regulatory Milestone Events set forth below with respect to the first Co-Co Product that achieves such event. For clarity, each milestone set forth below shall be due and payable one time only (regardless of the number of Co-Co Products to achieve any such Regulatory Milestone Event). CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Regulatory Milestone Event (For the first Co-Co Product that achieves such event) Milestone Payments (in $ millions) [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] For each of Paragraphs (1) - (3) of this Exhibit C-2, the Parties understand and agree that in no event will more than one (1) milestone payment be paid with respect to any specific event triggering a payment under this Jounce Lead Co-Co Agreement.

  • Milestone A principal event specified in the Contract Documents including the Material Completion and Occupancy Date and other events relating to an intermediate completion date or time.

  • Milestones Subject to the provisions of the SGIP, the Parties shall agree on milestones for which each Party is responsible and list them in Attachment 4 of this Agreement. A Party’s obligations under this provision may be extended by agreement. If a Party anticipates that it will be unable to meet a milestone for any reason other than a Force Majeure event, it shall immediately notify the other Parties of the reason(s) for not meeting the milestone and (1) propose the earliest reasonable alternate date by which it can attain this and future milestones, and (2) requesting appropriate amendments to Attachment 4. The Party affected by the failure to meet a milestone shall not unreasonably withhold agreement to such an amendment unless it will suffer significant uncompensated economic or operational harm from the delay, (1) attainment of the same milestone has previously been delayed, or (2) it has reason to believe that the delay in meeting the milestone is intentional or unwarranted notwithstanding the circumstances explained by the Party proposing the amendment.

  • Sales Milestones Subject to the terms and conditions set forth in the Agreement, in the event that the Annual Net Sales made by or on behalf of a Selling Entity for all Licensed Products in a given calendar year first exceeds a threshold set forth in the table immediately below, Pyxis shall pay to LCB the following one-time, non-refundable, non-creditable milestone payments. Annual Net Sales Milestone Threshold Payment (US Dollars) [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] In the event that in a given calendar year more than one (1) Annual Net Sales milestone threshold is achieved, Pyxis shall pay to LCB each separate Annual Net Sales milestone payment with respect to each Annual Net Sales milestone threshold that is achieved in such calendar year. Pyxis shall notify LCB in writing upon the first achievement, in respect of a Licensed Product, by or on behalf of Pyxis or its Affiliate or Sublicensee, of each of the Milestones set forth in Section 5.2 (Development Milestones), Section 5.3 (Regulatory Milestones) and Section 5.4 (Sales Milestones) no later than [***] of Pyxis’s knowledge of achievement thereof, and in any event, each of the Milestones set forth in Section 5.4 (Sales Milestones) no later than [***] after the end of the applicable calendar year in which such Milestone is achieved. No later than [***] of receipt of an appropriate invoice from LCB, Pyxis shall pay the applicable payment due upon achievement of the corresponding Milestone Event. Each Milestone Event shall be deemed to be achieved once for all Licensed Products and shall be payable only once.

  • Commercial Milestone Payments For each Licensed Product, Licensee shall pay Arvinas the following one-time milestone event payments when the aggregate Net Sales of such Licensed Product in one or more particular country(ies) for a given calendar year (“Annual Net Sales”), where such Licensed Product is a Valid Claim Licensed Product at the time of sale in each of such country(ies), first achieves the corresponding threshold as set forth in this Section 6.3.2 below, subject to the terms of this Section 6.3 and the payment provisions in Article 7 below: Commercial Milestone Event Milestone Event Payment (US$)

  • Development and Regulatory Milestones With respect to each of the following milestones, Ikaria shall pay BioLineRx the corresponding payment set forth below within [**] days after the achievement by Ikaria, its Affiliates or Licensees of such milestone: MILESTONE PAYMENT

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!